Influenza Vaccines Market Share PowerPoint PPT Presentations

Global influenza vaccines market size is expected to reach $10.1 Bn by 2028 at a rate of 8.0%, segmented as by vaccine type, inactivated, live attenuated

DPI Research has published a new research report titled “United States Influenza Vaccines Market Size, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2031 ” in its research database. The influenza vaccines market in the United States was valued at US$ 3,962 million in 2022 and is expected to reach US$ 8,347 million by 2031, registering a CAGR of 8.6% during the forecast period.

This report provides a complete analysis of 4 East Europe Countries (Hungary, Romania, Slovakia and Slovenia), Seasonal Influenza Vaccine Market in Infant & Adult population.

iGATE Research has released a research report on “Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024” Click here to view the complete report: http://igateresearch.com/FullReportDetail.php?p=128 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com

The 7 major seasonal influenza markets reached a value of US$ 8.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 41.6 Billion by 2034, exhibiting a growth rate (CAGR) of 15.08% during 2024-2034.

Read here the latest updates on the Pneumococcal Vaccines Market published by the CMI team.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue million USD, market share and growth rate of Influenza Vaccines in these regions, from 2013 to 2025 forecast, covering North America Europe China Japan Southeast Asia India

Bharat Book Bureau provides the report; on “Global Influenza Vaccines Market”. (https://www.bharatbook.com/healthcare-market-research-reports-644661/global-influenza-vaccines-persons-vaccinated-brand-analysis.html) The report provides detailed analysis of Global Influenza Vaccines Market with respect to major segments such as type, structure and product, and comprehensive analysis of market dynamics including factors and opportunities is included in the report.

Global influenza vaccines market size is expected at $9.28 Bn by 2027 at a growth rate of 7.63% and share analysis by The Business Research Company.

TBRC veterinary antibiotics market report includes anti-parasitic, anti-bacterial, non-steroidal anti-inflammatory drug http://bit.ly/3UIyZRK

marketreportslibrary.com published a study on the “EMEA Avian Influenza Vaccines Market” that contains Competitive Analysis and the recent trends and opportunities.

iGATE Research (www.igateresearch.com) report titled Influenza Vaccines Market and Forecast - Global Analysis provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 176 Page report contains 117 Figures and 8 Tables to present a clear picture of the influenza vaccines market landscape. The Influenza Vaccines Market have been analyzed from 4 viewpoints: 1. Influenza Vaccines Market, Persons Vaccinated and Forecast - Geographical Distribution (2011 - 2021) 2. Global - Influenza Vaccines Brand Sales and Forecast to 2021 3. Global Influenza Vaccines Market - Major Deals 4. Global Influenza Vaccines Market - Driving Factors and Challenges

The European influenza vaccines market is anticipated to reach nearly US$ 650 Million by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide Complete report available at: http://www.marketreportsonline.com/545525.html.

In the Americas, United States captures majority of the influenza vaccines market share. Brazil is the second leading market for influenza vaccines with around XX% share in 2015. Canada and Mexico are the third and fourth leading market for influenza vaccines with XX% and XX% market share respectively in 2015. In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market. Complete report available at: http://www.marketreportsonline.com/545524.html

Global adult vaccines market size is expected at $6.63 Bn by 2027 at a growth rate of 6.26% and growth analysis by The Business Research Company.

Veterinary Vaccines Market 2020 Analysis and Review of Veterinary Vaccines Market by Product - Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines for 2020-2030

Big Market Research “Veterinary / Animal Vaccines Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2020. Visit for more info @ http://www.bigmarketresearch.com/veterinary-animal-vaccines-mnm-market The Veterinary / Animal Vaccines Market, report segments the veterinary vaccines market on the basis of products, diseases, technologies, and regions. On basis of products, the veterinary vaccines market is categorized into companion animal vaccines, livestock vaccine, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines, and other animal vaccines.

Porcine Vaccine Market size is estimated to reach $2.12 billion by 2027, growing at a CAGR of 7.1% during the forecast period 2022-2027.

The report titled “Global Influenza Drugs and Vaccines Market : Opportunities and Forecast (2016-2021). For more mail info@azothanalytics.com

The global vaccines market is expected to reach 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3%. The global market is broadly classified into technology, type, disease indication, end-users, and regions.

Industry Experts unveiled the new market research report on Influenza. The new global report ‘Global Influenza Market – Vaccines and Therapeutics’ reveals that the market for seasonal influenza vaccines is estimated at 543 million doses valued at US$4.9 billion in 2016 and projected to touch US$714 million doses equated to US$7.9 billion by 2022. In terms of market value, North America is estimated the largest market with US$2.1 billion in 2016 while Europe is projected to be the fastest growing market for Influenza vaccines during the analysis period 2016-2022 with a CAGR of 11.7%. Hyderabad, India based Industry Experts is a multi industry focused business information provider. For more details, please visit http://industry-experts.com/verticals/healthcare-and-pharma/global-influenza-market-vaccines-and-therapeutics

According to Cognitive Market Research, The Global Chicken vaccine market will be USD XX million in 2023 and expand at a CAGR of 8.00% from 2023 to 2030.

Influenza Vaccine Market, by Type (Seasonal Influenza, Pandemic Influenza, Zoonotic Influenza), Technology (Virus-Like Particles Influenza Vaccine, Vectored Influenza Vaccine, Cell-Based Produced LAIV), End-User (Research Centers, Hospitals, Clinics) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

The global animal vaccines market size is expected to reach USD 16.27 billion by 2028 according to a new study by Polaris Market Research.

Companion Animal Segment to Lead Market for Global Veterinary Vaccines Market with Increasing Number of Pet Ownership Worldwide: Fortune Business Insights https://www.fortunebusinessinsights.com/industry-reports/veterinary-animal-vaccines-market-101532

iGATE RESEARCH report entitled “Global - Adult Vaccines Market & Company Analysis to 2020” is a 232 page report with 142 Figures and 8 Tables. This report studies in detail the adult vaccines market disease wise, company wise sales analysis and strategic alliances, mergers and acquisitions along with growth drivers and hindrances for the vaccines market landscape. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=Global%20-%20Adult%20Vaccines%20Market%20%20Analysis%20to%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com

Big Market Research adds a report “Global Human Vaccine Market- Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast 2020" Get Complete Report @ http://www.bigmarketresearch.com/global-human-vaccine-market Human vaccines are of two types: preventable human vaccines and therapeutic human vaccines. Preventable human vaccines are used both for adults and children. Pediatric human vaccines are used to immunize children against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. Enquire about report @ http://www.bigmarketresearch.com/report-enquiry/385329

Global equine healthcare market size is expected to reach $1.81 Bn by 2028 at a rate of 6.2%, segmented as by product type, drugs, vaccines, medical feed additives

poultry vaccine market is anticipated to be valued at USD 2199.8 million in 2022 and is expanded to grow at a significant CAGR of 5.8% over 2023-2029

Seasonal Influenza Vaccination Market in Lithuania, Estonia, Latvia (Baltic Countries) By (Child & Adult) Forecast report published by Renub Research. According to this report, in the Baltic Countries, Lithuania is having the highest seasonal influenza vaccine market share followed by Latvia and Estonia. In terms of children vaccination, Lithuania & Latvia hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 95 percent market share by 2022. Download full Report: http://www.renub.com/seasonal-influenza-vaccination-market-in-lithuania-estonia-latvia-baltic-countries-by-child-and-adult-forecast-1017-p.php

According to the latest research report by IMARC Group, The global pediatric vaccines market size reached US$ 37.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 70.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.26% during 2024-2032. More Info:- https://www.imarcgroup.com/pediatric-vaccines-market

mRNA Vaccines Market

Vaccine is a preparation of weak or killed pathogen to stimulate the immunity process of the body. The vaccine market is a segment under the pediatric drugs market, which accounts to 80% of the pharmaceutical drugs market. The demand for pediatric vaccines is the major driving force of the market. Get access to detailed report at: https://www.alliedmarketresearch.com/vaccines-market

Read here the latest updates on the Latin America Pharmaceutical Products CMO Market published by CMI team.

Read here the latest updates on the Cell Culture Media for Vaccine Market published by the CMI team.

Vaccines can be defined as a product that stimulates a persons immune system to produce immunity to a specific disease, thereby protecting the person from that disease. Browse full report @ http://bit.ly/18nvh8U

Seasonal and Pandemic Influenza Vaccines: Vaccine Development and Production * Studies are being planned or are underway to determine dosing, safety, and antibody ...

Romania is having the highest seasonal influenza vaccine market share in East Europe Countries. In terms of children vaccination, Romania & Hungary together accounts for more than 40 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 80 percent market share by 2022. http://www.marketreportsonline.com/576704.html.

Big Market Research “Pediatric Vaccines Market 2022” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast

Paediatric Vaccine Market: Pneumococcal Indication Segment Anticipated to Be the Most Attractive Segment Through 2026: Global Industry Analysis and Opportunity Assessment, 2016-2026

iGATE RESEARCH report entitled “Global - Adult Vaccines Market & Company Analysis to 2020” is a 232 page report with 142 Figures and 8 Tables. This report studies in detail the adult vaccines market disease wise, company wise sales analysis and strategic alliances, mergers and acquisitions along with growth drivers and hindrances for the vaccines market landscape. Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=Global%20-%20Adult%20Vaccines%20Market%20%20Analysis%20to%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com

The global market size for human vaccines is anticipated to observe tremendous growth projections during 2019 – 2025. The prominent factors that are expected to contribute to the growth of the global human vaccines market during the forecast period: Increased Disease Awareness Approval/launches of the New Vaccines Rising focus on immunization programs Increasing government support for the vaccine development

Click here to view the complete report: http://www.igateresearch.com/ProductDetail.php?pd_name=Global%20-%20Adult%20Vaccines%20Market%20%20Analysis%20to%202020 Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-706-527-9335 (INDIA) Web: www.igateresearch.com

Influenza Vaccine Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. The report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report.

Animal/Veterinary Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] – Global Forecast to 2018 @ http://www.lifescienceindustryresearch.com/animalveterinary-vaccines-market-products-livestock-bovine-companion-canine-poultry-equine-diseases-rabies-distemper-foot-mouth-gumboro-avian-influenza-strangles-technology-live.html The global Animal Vaccines Market is in its growth phase and is poised to cross the $8 billion mark by 2018. The factors responsible for the growth of the market include increasing incidences of zoonotic diseases in humans; growing prevalence of animal diseases; and increasing investments by government bodies, animal welfare associations, and leading players. Another factor driving the growth in this space is the continuous innovations and introduction of new products in the market.

The global safety needles market is estimated to be valued at nearly US$ 4,000 Mn in 2017 and is anticipated to touch almost US$ 8,000 Mn by 2027 end, registering a CAGR of 6.9 % over the forecast period

Global Influenza Vaccination Market Information, by Influenza type (seasonal, pandemic, Zoonotic), by manufacturing technology (Egg Based Technology, Cell Culture Based Technology, Recombinant Technology) by End User (Hospital, Ambulatory, Research Laboratory and others) - Forecast to 2022

The United States pediatric vaccines are expected to remain highly active in the future, fueled by the encouragement and financing from Governments and other health organizations. To know more : https://www.bharatbook.com/healthcare-market-research-reports-666201/united-states-pediatric-vaccines-immunization.html

Sustained investments will play an instrumental role in the development of tailor-made flu vaccines, according to a new Persistence Market Research (PMR) study. The market value crossed its US$ 4 Bn mark in 2018, says the report.

Get more details @ http://bit.ly/2zKasVN Some of the major players in vaccines market are AstraZeneca, Abbott, Bristol-Myers Squibb, Merck & Co., Johnson & Johnson, Sanofi Pasteur, Pfizer, GlaxoSmithKline, Emergent BioSolutions, Novartis, Astellas Pharma, CSL and Novavax.

Big Market Research : Japanese Microbiology Testing Market : Trends, Size, Supplier Shares and Country Forecasts 2014 To Get More Details @ http://www.bigmarketresearch.com/future-horizons-and-growth-strategies-in-the-japanese-microbiology-testing-2014-supplier-shares-and-country-forecasts-market This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

GBI Research, the leading business intelligence provider has released its latest research “Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants” which essentially provides insights into the seasonal influenza vaccine sales forecasts for the Asia-Pacific Region until 2018. View full report with TOC: http://www.reportsandintelligence.com/seasonal-influenza-vaccine-in-asia-pacific-to-2018-positive-impact-of-government-support-offset-by-limited-production-capacity-high-investment-and-strict-regulations-as-barriers-to-new-entrants-market

The global pediatric vaccine market was valued at USD 24 Billion in 2015 and is anticipated to exhibit a robust compound annual growth rate (CAGR) of 10.6% over the forecast period.

Dengue Vaccine Market: Contribution of NGOs for Better Vaccine Access Expected to Drive the Market in Lower Income Countries: Global Industry Analysis & Opportunity Assessment, 2017 - 2027

Adult Vaccines Market is expected to be close to US$ 20 Billion by the year 2022. Because of vaccines, some diseases (like Polio and Diphtheria) are becoming rare. Vaccination can prevent certain deadly diseases in all age groups. Almost all countries around the world have introduced efficient National Immunization Programme in their vaccination schedule to overcome the epidemics caused by vaccine-preventable diseases. WHO’s Global Vaccine Action Plan, Global Immunization Vision and Strategy (GIVS), The GAVI Alliance all are putting their best to minimize the incidence of vaccine-preventable diseases which indeed is driving the adult vaccine market vigorously. Download full Report: http://www.renub.com/adult-vaccines-market-company-adult-vaccines-sales-country-adult-vaccines-worldwide-analysis-19-p.php

Bharatbook.com announces a new report on "Animal/Veterinary Vaccines Market , Diseases, Technology - Global Forecast to 2018". This research report categorizes the global animal/veterinary vaccines market on the basis of products, animal diseases, and technology. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2011, 2012, and 2013 as well as forecasts up to 2018.